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radiotherapy are planned, including specialized tools for 
quick visual evaluation and manual corrections. 
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Purpose/Objective: 4DCT allows visualisation of tumour and 
organs at risk motion over the whole breathing cycle. This 
enables the creation of an internal target volume and 
individualised planning margins. At UCLH previous practice 
for node positive lung cancer was to perform a helical scan 
plus IV contrast, to delineate the nodal areas. A region of 
interest 4DCT was then acquired for tumour motion. It was 
deemed not possible to maintain contrast enhancement 
through the entire total lung 4DCT. However, after 
discussions with the UCLH imaging department, from 
November 2013, a new practice to administer contrast whilst 
obtaining a total lung 4DCT scan was instigated. A 
retrospective audit was conducted to compare enhancement 
of the contrast in both practices and its acceptability for 
radiotherapy planning. 
Materials and Methods: The radiotherapy scans for 40 lung 
cancer patients were used to evaluate the enhancement of 
contrast throughout vascular structures. Retrospective 
evaluation of helical CT plus contrast followed by a regional 
4DCT of 20 patients and prospective evaluation of total lung 
4DCT plus contrast in 20 patients was performed. All patients 
received 100ml Omnipaque 350 mgI/mL intravenously in the 
arm. During the helical scan, a flow rate of 2-3ml/s and a 
time delay of 35 seconds were used. During the total lung 
4DCT scans, a flow rate of 1ml/s and a time delay of 45 
seconds were used. For each scan, on the axial slices an area 
profile of 9 x 9mm was created to determine the mean 
Hounsfield unit (HU) and standard deviation (SD) of the 
following structures: ascending aorta, right atrium, left 
ventricle, right ventricle and descending aorta at the inferior 
aspect of both the heart and lungs. This method is consistent 
with Cademartiri et al (2006). 
Results: The sample consisted of 29 males and 11 females 
with diagnoses of 11 NSCLC, 6 SCLC, 13 SCC, 8 
adenocarcinomas and 2 presumed lung cancers. 
 
 
The population mean HU and SD for the total lung 4DCT were 
lower compared to the helical scan (155HU ± 11) vs (233HU ± 
16). However, all total lung 4DCT plus contrast scans were 
clinically acceptable for radiotherapy purposes and none 
have been rejected due to limited contrast enhancement 
since the change of practice. 
Conclusions: The level of contrast enhancement within the 
total lung 4DCT scans is clinically acceptable for the purpose 
of delineation of thoracic target volumes and organs. A total 
lung 4DCT with contrast results in a lower CT dose to the 
patient than a helical scan with contrast followed by a 
regional 4DCT. This streamlined process reduces the scan 
time for the patient in the radiotherapy position which 
increases patient compliance. This new practice results in a 
single dataset which reduces the inherent error of co-
registering multiple datasets and reduces the risk of 
delineation on the incorrect dataset.  
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Purpose/Objective: Tracking, gating and free-breathing (FB) 
systems are three stereotactic body radiation therapy 
techniques (SBRT) which can be used for lung treatments. 
The purpose of this study is to look deeper in the advantages 
from one technique to the other by a dosimetric parameters 
comparison. 
Materials and Methods: Ten patients, previously treated 
using linac-based SBRT, were selected for this analysis. 4DCT 
data were acquired for each patient and sorted into 10 
phases of breathing cycle such as 0% and 50% phases defined 
respectively inhalation and exhalation maximum. GTVph, 
PTVph (=GTVph+3mm) and healthy irradiated lung were 
contoured on each phase. The prescribed dose was 60Gy in 4 
fractions. For tracking technique, 3D conformal SBRT with 9 
fields were planned for every phase and were summed. 
Tracking plans were normalized such as 99% dose covered 99% 
of PTVph and respected dose constraints of ROSEL study.  
Gating technique was analyzed with 3 exhalation phases (40-
50 and 60% phases). For free-breathing technique, ITVFB was 
created from a sum of all GTVph and 3mm margin on ITVFB 
defined a PTVFB. PTVFB was reported on each respiratory 
phase images and dose distributions were calculated. The 
dose normalization and dose constraints were the same as for 
tracking technique. Finally, 10 plans were summed. This 
method allowed knowing the dose really received by the GTV 
(from all GTVph) during a free-breathing irradiation.  
The 3 modalities were evaluated using dose-volume 
histograms of each GTVph and PTVph, homogeneity index 
(HI=(Dmax-Dmin)/Dmean) and the doses to healthy irradiated lung 
(Dmean and V20Gy). 
Results: Despite similar maximum doses, free-breathing 
system improved the target coverage by increasing Dmin and 
Dmean. Target coverage was slightly more homogeneous with 
this technique too. On the other hand, the healthy irradiated 
lung is better protected with tracking system even if dose 
constraints were respected in the 3 cases (V20Gy<10%). 
